Allen Hopper

Title: Innovations of Allen Hopper in Pharmaceutical Chemistry

Introduction

Allen Hopper is an accomplished inventor based in Cranberry, NJ (US). He holds a patent that showcases his contributions to the field of pharmaceutical chemistry. His work focuses on developing compounds that address various medical conditions, particularly those involving reactive oxygen species and inflammatory mediators.

Latest Patents

Hopper's notable patent is titled "Substituted 5-biphenyl-3,4-dihydroxy-2(5H)-furanones and method of use therefor." This invention relates to racemic or optically active 5-substituted 3,4-dihydroxy-2(5H)-furanone compounds and their pharmaceutically acceptable salts. These compounds are useful for treating a range of pathologies, including acute and chronic inflammatory disorders, neurodegenerative diseases, cardiovascular diseases, viral infections, skin conditions, and eye diseases.

Career Highlights

Allen Hopper is associated with Oxis Therapeutics Inc., where he applies his expertise in pharmaceutical development. His innovative approach has led to advancements in treatments for serious health conditions, demonstrating his commitment to improving patient outcomes.

Collaborations

Hopper has collaborated with notable colleagues, including Georges Apéré and Irene Erdelmeier. These partnerships have contributed to the success of his research and the development of his patented inventions.

Conclusion

Allen Hopper's work exemplifies the impact of innovation in the pharmaceutical industry. His patented inventions hold promise for treating various medical conditions, showcasing the importance of research and development in healthcare.